FALCON POINT CAPITAL, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 73 filers reported holding NEOS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$350,000
-83.7%
72,201
-78.9%
0.08%
-82.1%
Q2 2018$2,141,000
-34.4%
342,621
-12.9%
0.42%
-35.7%
Q1 2018$3,266,000
+396.4%
393,512
+509.8%
0.65%
+488.3%
Q4 2017$658,000
-45.4%
64,530
-44.3%
0.11%
-36.6%
Q3 2017$1,205,000
+35.9%
115,869
-4.7%
0.18%
+45.8%
Q2 2017$887,000
+39.5%
121,563
+37.7%
0.12%
+41.2%
Q1 2017$636,000
+26.9%
88,279
+3.1%
0.08%
+26.9%
Q4 2016$501,000
+22.8%
85,588
+23.8%
0.07%
+8.1%
Q3 2016$408,00069,1350.06%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders